IPCA Laboratories
Dr. Indranil Purkait is a seasoned professional in the medical affairs sector with extensive experience in leading teams and managing diverse medical divisions. Currently serving as Senior General Manager at Ipca Laboratories Limited since March 2017, Dr. Purkait oversees a team of 16 medical advisors. Prior roles include General Manager at Abbott and various senior positions at MSD, where responsibilities encompassed cardiology, respiratory, dermatology, and contraception. With a solid foundation in clinical practice, including roles as a Speciality Registrar and Medical Officer in the NHS, Dr. Purkait's academic qualifications include an MBBS from Medical College and Hospital, Kolkata, and a Senior Management Program from the Indian Institute of Management Ahmedabad.
This person is not in any teams
IPCA Laboratories
3 followers
Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs). It offers APIs, such as atenolol, hydroxychloroquine sulfate, morantel citrate, pyrantel pamoate and zaltoprofen. It offers brands, such as Zerodol, Lariago, HCQS Perinorm, Rapither, Tenoric, Lumerax, Etova, Malirid and Folitrax. Its 3c division focuses on cardiovascular and anti-diabetic markets. Its 3d division is focused on cardio-diabetic market. The Company's activa division serves the rheumatology market. Its altus division caters to the needs of intensivists, both surgical and non-surgical. Its Bionova division's focus area is dermatology. Its dynamix division focuses on cardiovascular, gastro-intestinal, anti-bacterial, pain management and respiratory sectors. It hycare division caters to the needs of cardiologists and diabetologists. Its divisions also include innova, intima, pain management, pharma and uro sciences.